Oral Presentations September 23Rd - Rooms 1,2 and 3

Oral Presentations September 23rd - Rooms 1,2 and 3 <ul style="display: flex;"><li style="flex:1">Presentation Date </li><li style="flex:1">Abstract </li></ul>Code <ul style="display: flex;"><li style="flex:1">Authors </li><li style="flex:1">Presenter´s name - </li></ul>indicated by the author <ul style="display: flex;"><li style="flex:1">Theme </li><li style="flex:1">Title </li></ul><ul style="display: flex;"><li style="flex:1">18498 </li><li style="flex:1">Thomas Smits; Femke Gresnigt; </li></ul>Eric Franssen; Milly Attema-de Jonge <ul style="display: flex;"><li style="flex:1">Thomas Smits </li><li style="flex:1">Clinical Toxicology/drugs of PERFORMANCE OF AN IMMUNOASSAY </li></ul><ul style="display: flex;"><li style="flex:1">abuse </li><li style="flex:1">METHOD FOR GAMMA-HYDROXYBUTYRIC </li></ul>ACID (GHB) IN PATIENTS PRESENTED AT THE EMERGENCY DEPARTMENT, A PROSPECTIVE STUDY 18499 18730 Thomas Smits; Femke Gresnigt; Milly Attema-de Jonge; Eric Fransse Thomas Smits Lea Wagmann Clinical Toxicology/drugs of DO WE NEED POINT-OF-CARE TESTING OF <ul style="display: flex;"><li style="flex:1">abuse </li><li style="flex:1">GAMMA-HYDROXYBUTYRIC ACID (GHB) AT </li></ul>THE EMERGENCY DEPARTMENT? Lilian H.J. Richter; Julia Menges; Lea Wagmann; Simon D. Brandt; Folker Westphal; Veit Flockerzi; Markus R. Meyer Clinical Toxicology/drugs of NEW PSYCHOACTIVE SUBSTANCES: September 23 13:30 - 14:45 ROOM 1 <ul style="display: flex;"><li style="flex:1">abuse </li><li style="flex:1">METABOLIC FATE, ISOZYME-MAPPING, </li></ul>AND PLASMA PROTEIN BINDING OF 5-APB- NBOME, 2C-B-FLY-NB2ETO5CL, AND 2C-B- FLY-NBOME 18985 18740 Annelies Cannaert; Marie Deventer; Melissa Fogarty; Amanda L.A. Mohr; Christophe P. Stove Souleiman El Balkhi ; Roland Lawson; Franck Saint-Marcoux Annelies Cannaert Souleiman El Balkhi Clinical Toxicology/drugs of HIDE AND SEEK: OVERCOMING THE <ul style="display: flex;"><li style="flex:1">abuse </li><li style="flex:1">MASKING EFFECT OF OPIOID </li></ul>ANTAGONISTS IN ACTIVITY-BASED SCREENING TESTS Clinical Toxicology/drugs of METABOLIC INTERACTIONS BETWEEN <ul style="display: flex;"><li style="flex:1">abuse </li><li style="flex:1">OXYCODONE, BENZODIAZEPINES OR </li></ul>DESIGNER BENZODIAZEPINES PLAY AN IMPORTANT ROLE IN OXYCODONE INTOXICATIONS <ul style="display: flex;"><li style="flex:1">19050 </li><li style="flex:1">Brenda de Winter F de Velde; MN Brenda de Winter </li></ul>Neely; WM Yamada; BCP Koch; S Harbarth; E von Dach; T van <ul style="display: flex;"><li style="flex:1">Anti-infective drugs </li><li style="flex:1">POPULATION PHARMACOKINETICS OF </li></ul>IMIPENEM IN CRITICALLY ILL PATIENTS: A COMPARISON BETWEEN PARAMETRIC AND <ul style="display: flex;"><li style="flex:1">NONPARAMETRIC METHODS </li><li style="flex:1">Gelder; A Huttner; JW Mouton </li></ul><ul style="display: flex;"><li style="flex:1">18941 </li><li style="flex:1">Léonard De Vinci Kanda Kupa; </li></ul>Camila Salinas Guillaux; Edvaldo Vieira de Campos; João Manoel da Silva Junior; Amanda Maria Ribas Rosa de Oliveira; Elson Mendes Silva Junior; Gabriela Aparecida Ferreira ; Thiago Camara Oliveira; Silvia Regina Cavani Jorge Santos; David de Souza Gomez Léonard de Vinci Kanda Kupa <ul style="display: flex;"><li style="flex:1">Anti-infective drugs </li><li style="flex:1">ASSESSMENT OF MEROPENEM </li></ul>PHARMACOKINETICS AT THE EARLIER VERSUS LATE PERIOD SEPTIC SHOCK IN ADULT CRITICALLY BURN PATIENTS BASED ON DRUG SERUM MEASUREMENTS DONE IN A REALtime <ul style="display: flex;"><li style="flex:1">19011 </li><li style="flex:1">Jean-Baptiste FOULQUIER; Fabilen Florian Lemaitre </li></ul>FILY; Marie-Clémence VERDIER; Matthieu REVEST; Camille TRON; Cédric ARVIEUX; Antoine PETITCOLLIN; Pierre TATTEVIN; Jean-LOUIS POLARD; Denis <ul style="display: flex;"><li style="flex:1">Anti-infective drugs </li><li style="flex:1">DEVELOPMENT OF A TOOL FOR OFLOXACIN </li></ul>AND LEVOFLOXACIN THERAPEUTIC DRUG MONITORING IN BONE AND JOINT INFECTIONS September 23 13:30 - 14:45 ROOM 2 HUTEN; Eric Bellissant; Bruno LAVIOLLE; Florian LEMAITRE <ul style="display: flex;"><li style="flex:1">19014 </li><li style="flex:1">Paul Ken Leong Chin; Sharon Jane Paul Chin </li></ul>Gardiner; Philip George Drennan; Michael Maze; Michaela Beattie; Daniel Frank Broughton Wright; Stephen Chambers Anti-infective drugs Anti-infective drugs VANCOMYCIN DOSING TARGETING TROUGH CONCENTRATIONS LEADS TO UNNECESSARILY HIGH DRUG EXPOSURE 19100 19047 Miao Yan; Dan Tang; Bai-Li Song; Miao Yan Min Zhang; Feng Wang; Da-Xiong Xiang VORICONAZOL THERAPY OPTIMIZATION BASED ON TOTAL BILIRUBIN IN PATIENTS WITH LIVER DYSFUNCTION Vikram Suryaprakash Gota; Murari Vikram Suryaprakash Gota TDM in Oncology Gurjar; Hasmukh Jain; Manju Sengar PRETREATMENT TPMT ACTIVITY AND ERYTHROCYTE 6-TGN LEVELS ARE PREDICTORS OF TOXICITY OF 6- MERCAPTOPURINE IN ACUTE LYMPHOBLASTIC LEUKEMIA 18907 18263 18928 <ul style="display: flex;"><li style="flex:1">Brenda Marisol Del Valle Monge; Brenda Marisol Del Valle TDM in Oncology </li><li style="flex:1">COMPARISON OF TWO PHARMACOKINETIC </li></ul>SOFTWARE TOOLS FOR THERAPEUTIC DRUG MONITORING OF FLUOROURACIL (5- FU) <ul style="display: flex;"><li style="flex:1">Patricia Kleiner; Ulrich Jaehde </li><li style="flex:1">Monge </li></ul>Lisa Stamp; Peter Chapman; Murray Barclay; Anne Horne; Tony Merriman; Daniel Wright; Jill Drake; Nicola Dalbeth <ul style="display: flex;"><li style="flex:1">Murray Barclay </li><li style="flex:1">Pharmacogenetics </li></ul>Pharmacogenetics RELATIONSHIPS BETWEEN ALLOPURINOL DOSE, OXYPURINOL LEVELS AND SERUM URATE Natalie Espinoza Giacomozzi; Carolina Salas Palma; Mauricio Farfán Urzúa Natalie Espinoza Giacomozzi FREQUENCY OF THE CYP2C19*17 POLYMORPHISM IN A CHILEAN POPULATION AND ITS EFFECT ON VORICONAZOLE PLASMA CONCENTRATION IN IMMUNOCOMPROMISED CHILDREN September 23 13:30 - 14:45 ROOM 3 <ul style="display: flex;"><li style="flex:1">18992 </li><li style="flex:1">Nicolas Picard; Chantal Barin-Le </li></ul>Guellec; Séverine Cunat; Tiphaine De Beaumais; Alexandre Evrard; Xavier Fonrose; Marie-Claude Gagnieu; Elodie Gautier; Vincent Haufroid; Fabien Lamoureux; Litaty Mbatchi; Céline Narjoz; Léa Payen; Sylvie Quaranta; Fabienne Thomas; Céline Verstuyft; MarieAnne Loriot; Jean-Christophe Boyer <ul style="display: flex;"><li style="flex:1">Nicolas Picard </li><li style="flex:1">Pharmacogenetics </li><li style="flex:1">A CONSENSUAL PANEL FOR NEXT- </li></ul>GENERATION SEQUENCING IN PHARMACOGENETICS FROM THE FRENCH NATIONAL NETWORK OF PHARMACOGENETICS (RNPGX) <ul style="display: flex;"><li style="flex:1">18299 </li><li style="flex:1">Lisa Stamp; Paula Keating; Paul </li></ul>Hessian; Murray Barclay; John O'Donnell <ul style="display: flex;"><li style="flex:1">Murray Barclay </li><li style="flex:1">Other theme </li><li style="flex:1">RELATIONSHIP BETWEEN ADALIMUMAB </li></ul>CONCENTRATIONS, ANTI-DRUG ANTIBODIES AND DISEASE ACTIVITY IN A CROSS SECTION OF RHEUMATOID ARTHRITIS PATIENTS

Oral Presentations September 23Rd - Rooms 1,2 and 3

Details

Download

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

Support